๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Vaginal cytology as an aid to hormone therapy in postmenopausal cancer of the breast

โœ Scribed by Basil A. Stoll

Publisher
John Wiley and Sons
Year
1967
Tongue
English
Weight
634 KB
Volume
20
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Polymorphisms in genes of the steroid re
Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy
โœ The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone The ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 183 KB ๐Ÿ‘ 1 views

## Abstract Menopausal hormone therapy (HT) is associated with increased breast cancer risk among postmenopausal women. Nuclear receptors are involved in steroid hormoneโ€ and xenobioticโ€mediated signal transduction playing a crucial role in regulating gene expression. Therefore, variations within t

Glycolysis and glucose transporter 1 as
Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer
โœ Dalia Rivenzon-Segal; Swetlana Boldin-Adamsky; Dalia Seger; Rony Seger; Hadassa ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 167 KB

## Abstract Estrogen plays a key role in the development and progression of breast cancer; hence, antiestrogens, such as tamoxifen, have a marked impact on the treatment and outcome of breast cancer patients. Estrogenโ€induced growth requires continuous replenishment of energy, predominantly generat

Comparison of anastrozole versus tamoxif
Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer : The pre-operative โ€œArimidexโ€ compared to Tamoxifen (PROACT) trial
โœ Luigi Cataliotti; Aman U. Buzdar; Shinzaburo Noguchi; Jose Bines; Yuichi Takatsu ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 193 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND The Preโ€Operative โ€œArimidexโ€ Compared to Tamoxifen (PROACT) study was a randomized, multicenter study comparing anastrozole with tamoxifen as a preoperative treatment of postmenopausal women with large, operable (T2/3, N0โ€2, M0), or potentially operable (T4b, N0โ€2, M0) br